From centuries Swarna Bhasma (incinerated gold) is used as a medicine in the Indian traditional system of medicine. Numbers of its properties were mentioned in the classical texts of Ayurveda like rejunavator, aphrodisiac, memory booster etc. [1] It is used in numerous disorders like Grahani (sprue), Pandu (anemia), Asthikshaya (osteoporosis), Jirna Vyadhi (chronic disorders) etc. [2] It is chief ingredient in therapeutically potent medicines like Makaradhwaja, Swarna Malini Vasanata, Vasantakusumakara Rasa. Its few therapeutic properties like analgesic [3] anticataleptic, anti anxiety and antidepressant [4] , activity antioxidant [5] and augmenting effect [6] were screened earlier. Its role on a normozoospermia, [7] male infertility [8] and oligoazospermia [9] was found to have significant results also specific quantity of gold was observed in semen of healthy fertile men. [10] [11] Recent studies of gold nanoparticles were found effective for antiangiogenic and anti cancer property. [12] Swarna Bhasma is used as a chief ingredient in Swarna Prashana for neonates and children. It was advocated in the classical texts of Ayurveda that Swarna Prashana acts as Rasayana (immunomodulation) and increases Dhi (memory) in neonates and children. [13] [14] Nowadays, Ayurveda physicians are prescribing Swarna Prashana to children and neonates with claim of immunity booster in modified drop format. Many manufacturers have also manufactures Swarna Prashana drops and selling them on medical counters. Though classical texts of Ayurveda mentioned Swarna Prashana for Rasayana activity but its procedure is different from this modified drop format. So to analyze its efficacy as an immunity booster here in present it was planned to prepare Swarna Prashana Drops and evaluate its immune-modulatory activity.
MATERIALS AND METHODS

Preparation of Swarna Bhasma
Swarna Bhasma was prepared by following classical reference and standard guidelines in the department of Rasashastra and Bhaishjya Kalpana, Institute of Post Graduate Teaching and Research in Ayurveda (IPGT&RA), Gujarat Ayurved University (GAU), Jamnagar. [15] [16] [17] 24 caret hallmark certified gold was purchased from local gold market of Jamnagar. Thin flakes of gold were prepared by roller press. These flakes were equally weighed and used for the Shodhana procedure (purification and potentiating procedure). [18] After Shodhana, gold flakes were converted into small pieces. These small pieces of purified gold were amalgamated with purified mercury (Shuddha Parada) [19] followed by triturating with purified sulfur (Shuddha Gandhaka) [20] up to preparation of black colored homogeneous mass. The material was milled with decoction of bark of Bahuana Verigate (Kanchanaara Twaka) and semisolid mass was prepared. Small pellets were prepared from this semisolid mass and dried. These dried pellets were kept inside earthen pot and burned within heat of 8 cow dung cakes. The procedure was repeated for thirty subsequent times up to achievement of Rekhapurnatva and Varitaratva (characteristic features) of Swarna Bhasma. 52.65 % elemental gold was observed in the finished product on the inductively coupled Plasma Atomic Emission Spectrometry analysis [21] . The Bhasma was stored and used for the experiment. Cow ghee, Honey and Vacha Churna (Acorus calamus Linn.) were procured from the Pharmacy of GAU, Jamnagar. Swarna Prashana was prepared by adding Swarna Bhasma 30 mg and Vacha Churna (Acorus calamus Linn.) 30 mg in agate mortar and pestle and milled with gentle pressure till homogenous preparation. The mixture was again triturated with 70 ml honey and cow ghee 70 ml up to homogeneous emulsion formation. The prepared emulsion was designated as SBP and kept in air tight glass container for further experimental use. [13] [14] Experimental Animals Charle's Foster albino rats (180 to 220 g) of either sex were procured from the Animal house of Pharmacology laboratory of IPGT & RA, GAU, Jamnagar. After obtaining permission from animal ethical committee (IAEC 12/2012/02) experiments were carried out. Amrut brand rat pellet feed supplied by Pranav Agro Ltd. was fed to animals during the study period. The drinking water was given ad libitum in polypropylene bottles with stainless steel sipper tube. Groups: Experimental study was carried out on 6 animals in each group; SRBC (Sheep red blood corpuscles control group) and SBP (Swarna Prashana group).
Dose fixation
The dose of the drug was calculated by extrapolating the therapeutic dose to rat on the basis of body surface area ratio by referring to the table of Paget and Barnes (1964) . [22] Human dose of Swarna Bhasma 15 mg was considered as a therapeutic dose. [15] It was converted to rat dose by applying conversion formula of Paget and Barnes. SBP emulsion was administered orally at dose 1 ml/ 200 g body weight, to test drug group SBP animals. Humoral Immune response Sheep blood was collected aseptically from the city slaughter house in a sterilized bottle containing Elsevier's solution (2% Dextrose, 0.8% sodium citrate, 0.05% citric acid and 0.42% sodium chloride). Blood was centrifuged in cooling centrifuge at 3000 RPM (rate per minute). Sheep red blood corpuscles (SRBC) were collected and thoroughly washed with sterile normal saline and stored in a refrigerator till experimentation. SRBC from the same animal was used both for sensitizing and to determine antibody titre. Humoral immune response activity was carried as per method described by Stone and Paget (1971) with slight modification as per experiment. [23] Test drugs and vehicle were administered for 10 consecutive days. On the third day of test drug administration, all rats were antigenically challenged by subcutaneous injection of 30% v/v SRBC in the dose of 1 ml /200g body weight in the nape of neck. On the 11 th day, blood was collected by retro orbital puncturing under light anesthesia by using anesthetic ether. Blood was collected for hematological parameters and serum for evaluating haemagglutination antibody titre. All animals were sacrificed and spleen, thymus and lymph node were carefully dissected out, after noting its weight; they were transferred to 10% formalin solution for histopathological study.
Haemagglutination antibody titre
The microtitre plate was cleaned by distilled water and dried properly. 0.1 ml of sterile normal saline was added to each well of micro titre plate. Complement in the serum was inactivated by heating it at 56°C for 30 minutes in a serological water bath. Serial two fold dilutions of the serum were performed in sterile saline solution and 0.1 ml of each dilution was aliquoted into 96 well micro titre plate (16 well dilutions for each sample). 0.1 ml of sterile 3% v/v SRBC in normal saline was added and mixed. The plates were incubated for 8 hours and examined visually for agglutination. Highest serum dilution value causing haemagglutination was considered as the antibody titre and titre was converted to log2 values for easy comparison.
Cell mediated immunity
The test drug was evaluated to assess its effect on cell-mediated immunity against triple antigen mediated immunological oedema. The suspension of triple antigen with alum precipitate prepared in the proportion (Triple Antigen: 1 ml + Normal saline (0.9%) 4 ml+Potash Alum (10%) 1 ml). pH of the above solution was adjusted between 5.6 to 6.8 by using 10% sodium carbonate. Initially the rats were antigenically challenged by injecting the suspension of triple antigen with alum precipitates subcutaneously in the nape of the neck in a dose of 1 ml/200g body weight. [24] Administration of test drugs and vehicle were started on the day of sensitization and continued for the next five days. On 5 th day, 1 hour after administration the test drug, the rats were injected with 0.1 ml suspension of triple antigen with alum precipitates beneath plantar aponeurosis in the left hind paw. The paw volume was measured initially and 24, 48 hours after injecting this alum adjuvant. The paw volume was measured with the help of a digital plethysmograph. Percentage increase in paw volume after alum adjuvant injection in comparison to initial volume was noted. Values from control group were compared to the values from test drug administered groups. One way ANOVA followed by Dunnet's multiple 't' test for un paired data to determine significant difference between groups at p<0.05.
RESULTS AND DISCUSSION
The result showed that almost similar pattern of body weight gain were observed in treated group compared to control group whereas moderate insignificant decrease in spleen and thymus weight were observed in drug treated group (Table 1 and 2). (Table 3 ). Significant increase in antibody titre in SBP treated group was observed compared to control group ( Table 4 ). The result showed moderate insignificant increase in paw oedema after 24 hours and after 48 hours in treated group compared to SRBC group (Table 5) . Examination of sections of spleen, thymus and lymph node from control group exhibited normal cytoarchitecture (Figure 1-3) . The sections of SBP showed increase in the white pulp and cellularity in spleen along with mild increase in the cellularity of lymph node (Figure 1-2) . Normal cytoarchitecture of thymus was observed in SBP treated group (Figure 3) . Test drug, Swarna Prashana studied for its effect on SRBC induced humoral immune response in Albino rats. The humoral immunity involves interaction of B-cell with the antigen, and their subsequent proliferation and differentiation into antibody secreting plasma cells. Antibody functions as the effectors of the humoral response by binding to antigen and neutralizing it to form clusters that are more readily ingested by phagocytic cell. Both drugs enhanced the agglutination titre to SRBC (antigen) but significant increase was seen in SB treated group. This indicates the enhanced responsiveness of macrophages and T, B lymphocytes which are involved in antibody synthesis. [25] Increased level of antibodies gives higher agglutination titer against sheep red blood cells. [26] Control group and test drug treated groups showed consistent body weight gain throughout experimental period. The moderate insignificant decrease in spleen and thymus weight was observed in test drug treated animals. Generally decrease in the weight of the organ is indicative of loss of tissue mass in that organ, exception being the secretory organs in which decrease in weight sometimes is seen along with increased activity. In present study the findings of the histopathological study the weight reduction does not seem to represent loss in the tissue mass as no pathological changes was observed in histological study (Figure 1-3) . The significant increase was observed in platelet count in SBP treated group. Test drug moderately increased the values of WBC and lymphocytes which plays important role in immune activity. Test drug also moderately increased the level of RBC and haemoglobin which indicative of its role in red blood cell formation. [27] Histopathological studies show that SBP increased the cellularity in spleen and lymph node. Increase in cellularity in white pulp in spleen of test drug treated group may be due to the increase in lymphatic tissue and free lymphocytes in spleen. The increase in cellularity in the lymph node is indicative of increased immune activity. It may be due to increased formation of cytokines from the cells involved in immune mechanism. [28] Cell mediated immunity is a part of the process of graft rejection, tumour immunity and many intracellular infections or to micro-organisms, which cause chronic diseases. During delayed type hypersensitivity (DTH) responses, sensitized Tlymphocytes, when challenged by the antigen, are converted to lymphoblasts and secret lymphokines, attracting more scavenger cells to the site of reaction. [29] The infiltrating cells are immobilized to promote inflammatory reaction. [30] Test drug insignificantly influenced T-cell activity by increasing vascular permeability, vasodilatation, macrophage accumulation and activation, which finally result in the increase in the paw volume that promotes phagocytic activity. This behavior itself is suggestive of activation of immune system at cellular level with lymphocytes, Cytokines, prostaglandulin E etc.are also liberating from the neighboring cells. [25] CONCLUSION It could be concluded that, Swarna Prashana exhibited dramatic immunomodulatory effects in SRBC sensitized rats. Swarna Prashana non-significantly influenced T-cell activity which in turn increases vascular permeability, induce vasodilatation, macrophage accumulation and activation, and which finally result in the increase in the paw volume which promotes phagocytic activity. Swarna Prashana produces good humoral immune response. Therefore, findings provide experimental evidence that Swarna Prashana can be used to improve one's health and immune function efficiently. Further studies are required to develop an effective administration of Swarna Prashana, and to investigate the mechanism underlying the immunomodulation before administration in humans is performed.
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